Exagen (XGN) PT Raised to $15 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts XGN Hot Sheet
Price: $6.66 +1.22%
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity analyst Kyle Mikson raised the price target on Exagen (NASDAQ: XGN) to $15.00 (from $11.00) while maintaining a Buy rating.
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- SKF AB (SKFB:SS) (SKFRY) PT Raised to SEK270 at RBC Capital
- CMC Markets (CMCX:LN) (CCMMF) PT Raised to GBP7.60 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
